|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 217.7 INR | +3.42% |
|
-4.52% | -8.72% |
Indo Us Bio-Tech Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was INR 617.45 million compared to INR 500.53 million a year ago. Revenue was INR 617.66 million compared to INR 502.36 million a year ago.
Net income was INR 72.4 million compared to INR 52.67 million a year ago. Basic earnings per share from continuing operations was INR 3.755. Diluted earnings per share from continuing operations was INR 3.755.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.72% | 52.28M | |
| +51.85% | 57.87B | |
| +41.42% | 40.25B | |
| -5.25% | 39.94B | |
| -5.16% | 28.54B | |
| +12.79% | 26.4B | |
| -20.18% | 19.33B | |
| +30.88% | 12.4B | |
| +0.61% | 12.23B | |
| +25.06% | 12.2B |
INDO US BIO-TECH LIMITED 